Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Levosimendan by Tenax Therapeutics for Pulmonary Hypertension: Likelihood of Approval
Levosimendan is under clinical development by Tenax Therapeutics and currently in Phase III for Pulmonary Hypertension. According to GlobalData, Phase...
Data Insights
Levosimendan by Orion for Subarachnoid Hemorrhage: Likelihood of Approval
Levosimendan is under clinical development by Orion and currently in Phase II for Subarachnoid Hemorrhage. According to GlobalData, Phase II...